Hepatitis E seroprevalence in a German cohort of patients with inflammatory bowel diseases.
Peter HoffmannRouven BehnischJulia GsengerPaul SchnitzlerAnnika GaussPublished in: PloS one (2020)
In summary, we conclude that patients with UC have a higher anti-HEV IgG antibody prevalence than the general population in Germany, and that immunosuppressive therapy may carry no higher risk for HEV infection.